Associate Director, Pharmacoepidemiology Analytics
Current• Lead evidence/business insights generation across all phases, including identifying evidence gaps, designing studies, defining endpoints, executing research, and publishing results, to support late-stage or post-market oncology and other therapeutic area products.• Lead statistical analyses of real-world data (RWD) using claims and electronic medical records (EHR) databases, registries and clinical trial data.• Develop and execute epidemiological studies in support of regulatory filings such as Postmarket Requirements and Commitments (PMRs/PMCs), Post-Authorization Safety Studies (PASS), Post-Authorization Efficacy Studies (PAES), effectiveness studies of Risk Evaluation and Mitigation Strategy (REMS) or Risk Minimization Measures (RMMs), Drug Utilization Studies (DUS), Post-marketing Surveillance (PMS) studies, and other analyses.